EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 366 filers reported holding EXELIXIS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $397,203 | -1.4% | 17,677 | +4.1% | 0.00% | – |
Q1 2024 | $402,889 | -0.9% | 16,978 | +0.1% | 0.00% | – |
Q4 2023 | $406,701 | +4.6% | 16,953 | -4.7% | 0.00% | – |
Q3 2023 | $388,865 | +14.4% | 17,797 | +0.0% | 0.00% | – |
Q2 2023 | $339,967 | -18.2% | 17,790 | -16.9% | 0.00% | – |
Q1 2023 | $415,511 | +23.0% | 21,407 | +1.6% | 0.00% | – |
Q4 2022 | $337,883 | -0.9% | 21,065 | -2.9% | 0.00% | – |
Q3 2022 | $341,000 | -22.5% | 21,695 | +2.5% | 0.00% | – |
Q2 2022 | $440,000 | -8.9% | 21,156 | -0.7% | 0.00% | – |
Q1 2022 | $483,000 | +23.8% | 21,301 | -0.4% | 0.00% | – |
Q4 2021 | $390,000 | -19.4% | 21,377 | -6.8% | 0.00% | – |
Q3 2021 | $484,000 | +19.5% | 22,937 | +3.0% | 0.00% | – |
Q2 2021 | $405,000 | -19.8% | 22,260 | -0.3% | 0.00% | – |
Q1 2021 | $505,000 | +31.9% | 22,333 | +17.2% | 0.00% | – |
Q4 2020 | $383,000 | -0.3% | 19,063 | +21.4% | 0.00% | – |
Q3 2020 | $384,000 | -3.5% | 15,704 | -6.5% | 0.00% | -100.0% |
Q2 2020 | $398,000 | +83.4% | 16,804 | +33.4% | 0.00% | – |
Q1 2020 | $217,000 | 0.0% | 12,592 | +2.1% | 0.00% | – |
Q4 2019 | $217,000 | +4.3% | 12,332 | +4.9% | 0.00% | – |
Q3 2019 | $208,000 | -31.1% | 11,756 | -16.8% | 0.00% | – |
Q2 2019 | $302,000 | -66.1% | 14,131 | -62.3% | 0.00% | -100.0% |
Q1 2019 | $892,000 | +91.4% | 37,499 | +58.2% | 0.00% | 0.0% |
Q4 2018 | $466,000 | +6.9% | 23,698 | -3.3% | 0.00% | – |
Q3 2018 | $436,000 | +401.1% | 24,519 | +508.0% | 0.00% | – |
Q2 2018 | $87,000 | -15.5% | 4,033 | -13.8% | 0.00% | – |
Q1 2018 | $103,000 | -88.1% | 4,678 | -83.6% | 0.00% | -100.0% |
Q4 2017 | $867,000 | -45.7% | 28,535 | -56.8% | 0.00% | -50.0% |
Q3 2017 | $1,598,000 | -72.4% | 66,004 | -71.9% | 0.00% | -66.7% |
Q2 2017 | $5,788,000 | +3.0% | 234,997 | -9.3% | 0.01% | 0.0% |
Q1 2017 | $5,617,000 | +54.0% | 259,210 | +6.0% | 0.01% | +50.0% |
Q4 2016 | $3,647,000 | +12925.0% | 244,517 | +11014.4% | 0.00% | – |
Q3 2016 | $28,000 | +75.0% | 2,200 | +12.1% | 0.00% | – |
Q2 2016 | $16,000 | +128.6% | 1,962 | -2.4% | 0.00% | – |
Q1 2016 | $7,000 | -97.1% | 2,011 | -95.3% | 0.00% | – |
Q4 2015 | $242,000 | +106.8% | 42,587 | +104.2% | 0.00% | – |
Q3 2015 | $117,000 | +1200.0% | 20,855 | +789.7% | 0.00% | – |
Q2 2015 | $9,000 | +80.0% | 2,344 | +44.7% | 0.00% | – |
Q1 2015 | $5,000 | +25.0% | 1,620 | -55.2% | 0.00% | – |
Q4 2014 | $4,000 | -76.5% | 3,620 | -68.8% | 0.00% | – |
Q3 2014 | $17,000 | -10.5% | 11,620 | +106.8% | 0.00% | – |
Q2 2014 | $19,000 | +111.1% | 5,620 | +114.5% | 0.00% | – |
Q1 2014 | $9,000 | -25.0% | 2,620 | +31.0% | 0.00% | – |
Q4 2013 | $12,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q3 2013 | $12,000 | +33.3% | 2,000 | 0.0% | 0.00% | – |
Q2 2013 | $9,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |